Diane C. Young
CIK 1648010 · SVP, CHIEF MEDICAL OFFICER · last filed 2025-06-09
Diane C. Young is a SVP, CHIEF MEDICAL OFFICER who has filed 19 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for CLDX, was dated Jun 9, 2025. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $535.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$535.2K
2
19
-$2.49M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLDX | SVP, CHIEF MEDICAL OFFICER | 17,115 | $31.27 | $535.2K | -$2.48M | 12 | 2025-06-09 |
| Oncternal Therapeutics, Inc. (GTXI) Delisted | VP, Chief Medical Officer | 47,985 | — | — | -$3.9K | 7 | 2018-07-17 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-09 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | CLDX | Exer (M) | +15,000 | $40.6K | EDGAR |
| 2024-06-11 | CLDX | Sell (S) | −45,000 | -$1.59M | EDGAR |
| 2023-06-20 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2022-08-19 | CLDX | Mixed | +45,000 | -$389.5K | EDGAR |
| 2022-06-17 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2021-11-16 | CLDX | Mixed | — | -$149.8K | EDGAR |
| 2021-06-21 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2020-06-19 | CLDX | Grant (A) | — | $0 | EDGAR |